Dr Metters wrote to Dr Gunson, suggesting that the next ACVSB meeting should be brought forward and solely devoted to the question of whether routine anti-HCV screening of blood donations should commence, as "events are now moving fast." Read more about Dr Metters wrote to Dr Gunson, suggesting that the next ACVSB meeting should be brought forward and solely devoted to the question of whether routine anti-HCV screening of blood donations should commence, as "events are now moving fast."
Miss Keenay wrote a note to Dr Metters and the Parliamentary Secretary about testing for non-A non-B Hepatitis in donated blood, namely that there was insufficient data regarding the Ortho test to advise its routine introduction. Read more about Miss Keenay wrote a note to Dr Metters and the Parliamentary Secretary about testing for non-A non-B Hepatitis in donated blood, namely that there was insufficient data regarding the Ortho test to advise its routine introduction.
Dr Elwyn Elias of the Queen Elizabeth Hospital wrote to Dr Rejman, Department of Health, regarding the introduction of Hepatitis C testing of all blood donors in the UK. Read more about Dr Elwyn Elias of the Queen Elizabeth Hospital wrote to Dr Rejman, Department of Health, regarding the introduction of Hepatitis C testing of all blood donors in the UK.
Dr Boulton wrote to Dr Lloyd stating that Dr Lloyd's decision to start HCV-testing earlier than the other RTCs was "breaking ranks" and "not conducive to the image of a co-ordinated Service". Read more about Dr Boulton wrote to Dr Lloyd stating that Dr Lloyd's decision to start HCV-testing earlier than the other RTCs was "breaking ranks" and "not conducive to the image of a co-ordinated Service".
NBTS met to discuss provisional results obtained from the evaluation of the Ortho HCV kit at three blood transfusion centres, including surrogate testing, other studies, screening implications, replacement of donations that tested positive, confirmatory test protocol, supply of equipment from Ortho, and the cost of testing. Read more about NBTS met to discuss provisional results obtained from the evaluation of the Ortho HCV kit at three blood transfusion centres, including surrogate testing, other studies, screening implications, replacement of donations that tested positive, confirmatory test protocol, supply of equipment from Ortho, and the cost of testing.
A draft protocol of a pilot study to assess the introduction of routine anti-HCV tests in RTCs was completed, with the aims to conduct anti-HCV tests on circa 5000 donations in 1989, evaluate the performance of the test and assess the costs of screening other than the costs of test kits. Read more about A draft protocol of a pilot study to assess the introduction of routine anti-HCV tests in RTCs was completed, with the aims to conduct anti-HCV tests on circa 5000 donations in 1989, evaluate the performance of the test and assess the costs of screening other than the costs of test kits.
Dr Metters wrote a memo to Mr Hart, discussing ACVSB concerns regarding the Chiron test, Ortho offering free tests and Dr Gunson's views that Chiron would eventually be introduced. Read more about Dr Metters wrote a memo to Mr Hart, discussing ACVSB concerns regarding the Chiron test, Ortho offering free tests and Dr Gunson's views that Chiron would eventually be introduced.
Dr Mitchell reported back to the ACTTD that "The Chiron test is now being used in a large number of Blood Transfusion Laboratories throughout the World and one is struck by the rapidity of this introduction." Read more about Dr Mitchell reported back to the ACTTD that "The Chiron test is now being used in a large number of Blood Transfusion Laboratories throughout the World and one is struck by the rapidity of this introduction."
Dr Gunson wrote to Mr Graham Hart (Department of Health) regarding anti-HCV testing of blood donations, providing information regarding anti-HCV tests available from the Chiron Corporation, and provided estimate costings of pilot trials in RTCs. Read more about Dr Gunson wrote to Mr Graham Hart (Department of Health) regarding anti-HCV testing of blood donations, providing information regarding anti-HCV tests available from the Chiron Corporation, and provided estimate costings of pilot trials in RTCs.
Peter Savage advised Dr Gunson that FDA licensure of the ORTHO HCV antibody ELISA test was expected early first quarter of 1990. Read more about Peter Savage advised Dr Gunson that FDA licensure of the ORTHO HCV antibody ELISA test was expected early first quarter of 1990.